换一批
换一批Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.
第一作者：
Enrica Antonia,Martino
第一单位：
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
作者：
Enrica Antonia,Martino [1]
;
Daniele,Derudas [2]
;
Elena,Rossi [3]
;
Paola,Stefanoni [4]
;
Silvia,Mangiacavalli [5]
;
Elena,Zamagni [6]
;
Massimo,Offidani [7]
;
Anna,Furlan [8]
;
Angela Maria,Quinto [9]
;
Roberta,Della Pepa [10]
;
Giuseppe,Bertuglia [11]
;
Emiliano,Barbieri [12]
;
Concetta,Conticello [13]
;
Claudio,De Magistris [14]
;
Velia,Bongarzoni [15]
;
Anna Maria,Cafro [16]
;
Anna,Mele [17]
;
Cirino,Botta [18]
;
Nicola,Sgherza [19]
;
Giuseppe,Mele [20]
;
Ombretta,Annibali [21]
;
Angela,Rago [22]
;
Raffaele,Fontana [23]
;
Ernesto,Vigna [1]
;
Antonella,Bruzzese [1]
;
Katia,Mancuso [6]
;
Angela,Amendola [24]
;
Annalisa,Citro [25]
;
Emilia,Cotzia [26]
;
Sonia,Morè [7]
;
Elena,Rivolti [12]
;
Loredana,Pettine [14]
;
Monica,Galli [4]
;
Valerio,De Stefano [3]
;
Maria Teresa,Petrucci [3]
;
Alessandro,Corso [25]
;
Antonino,Neri [27]
;
Francesco,Di Raimondo [13]
;
Niccolò,Bolli [14]
;
Pellegrino,Musto [28]
;
Fortunato,Morabito [29]
;
Massimo,Gentile [30]
作者单位：
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.
[1]
Department of Hematology, Businco Hospital, Cagliari, Italy.
[2]
Section of Hematology, Catholic University, Fondazione Policlinico Gemelli IRCCS, Rome, Italy.
[3]
Hematology and Bone Marrow Transplant Unit, Bergamo, Italy.
[4]
Division of Hematology, IRCCS Fondazione Policlinico San Matteo, Pavia, Italy.
[5]
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy.;Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.
[6]
Hematology Unit, AOU delle Marche, Ancona, Italy.
[7]
Division of Hematology Ospedale Ca' Foncello di Treviso, Treviso, Italy.
[8]
Haematology and Transplant Unit, IRCCS - Istituto Tumori "Giovanni Paolo II", Bari, Italy.
[9]
Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
[10]
Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy.
[11]
Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
[12]
Division of Hematology, Azienda Policlinico-S. Marco, University of Catania, Catania, Italy.
[13]
Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
[14]
UOC of Hematology San Giovanni-Addolorata Hospital Rome Italy, Rome, Italy.
[15]
Department of Hematology, GOM Niguarda Hospital, Milan, Italy.
[16]
Haematology, Ospedale Cardinale Panico, Tricase, Italy.
[17]
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
[18]
Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.
[19]
Department of Hematology, Hospital Perrino, Brindisi, Italy.
[20]
Hematology, stem cell transplantation, Fondazione Policlinico Universitario Campus Bio medico di Roma, Rome, Italy.
[21]
UOSD Ematologia ASL Roma 1, Rome, Italy.
[22]
Hematology and Transplant Center, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Salerno, Italy.
[23]
Hematology Unit, Azienda Ospedaliera Regionale "San Carlo", Potenza, Italy.;Hematology Unit, Legnano General Hospital, Legnano, Italy.
[24]
Hematology Unit, Legnano General Hospital, Legnano, Italy.
[25]
Section of Hematology- Ospedale E. Muscatello-Augusta, Siracusa, Italy.
[26]
Scientific Directorate, Azienda USL-IRCCS di Reggio Emilia, Emilia, Italy.
[27]
Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Bari, Italy.;Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy.
[28]
Gruppo Amici Dell'Ematologia Foundation-GrADE, Reggio Emilia, Italy.
[29]
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.;Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.
[30]
主题词
人类(Humans);多发性骨髓瘤(Multiple Myeloma);女(雌)性(Female);男(雄)性(Male);老年人(Aged);中年人(Middle Aged);沙立度胺(Thalidomide);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);地塞米松(Dexamethasone);预后(Prognosis);抗体, 单克隆(Antibodies, Monoclonal);老年人, 80以上(Aged, 80 and over);成年人(Adult);抗药性, 肿瘤(Drug Resistance, Neoplasm);治疗结果(Treatment Outcome)
DOI
10.1002/hon.70042
PMID
39898517
发布时间
2025-02-05
- 浏览0
Hematological oncology
Hematological oncology
e70042页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
